The Viking Therapeutics Inc stock price today is What Is the Stock Symbol for Viking Therapeutics Inc? The stock ticker symbol for Viking Therapeutics. According to analysts, VKTX price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price. The bid & ask refers to the price that an. The average price target for Viking Therapeutics, Inc. comes to $ The forecasts range from a low of $ to a high of $ On average, Wall Street analysts predict that Viking Therapeutics's share price could reach $ by Jul 25, The average Viking Therapeutics stock price.
Viking Therapeutics Stock Price Prediction For 20 Viking Therapeutics stock prediction for December The forecast for beginning dollars. Stock Calculator. Investors. Overview · Stock Information · Stock Chart · Historical Price Lookup NASDAQVKTX. Investment Type. Amount invested (in dollars). Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Viking Therapeutics Inc has a consensus price target of $ based on the ratings of 15 analysts. The high is $ issued by Oppenheimer on March Track Viking Therapeutics Inc (VKTX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Viking Therapeutics (VKTX) has a Smart Score of 9 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Get Viking Therapeutics Inc (VKTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Analysts average stock forecasts to be materialized ratio is % with an average time for these price targets to be met of days. Highest price target. Analyst. Target Price. ; Earnings. EPS Forecast. Down ; Investor. New Investor. Avoro Capital Advisors Llc ; Insiders. Largest Sold. Sold K shares. Viking Therapeutics stock would need to gain 1,% to reach $1, According to our Viking Therapeutics stock forecast, the price of Viking Therapeutics. The lowest target is $90 and the highest is $ Please note analyst price targets are not guaranteed and could be missed completely. VKTX Analyst Ratings.
Average Recommendation, Buy. Average Target Price, Number Of Ratings, FY Report Date, 12/ Last Quarter's Earnings, Based on analysts offering 12 month price targets for VKTX in the last 3 months. The average price target is $ with a high estimate of $ and a low. View Viking Therapeutics, Inc. VKTX stock quote prices, financial information, real-time forecasts, and company news from CNN. Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. Stock Price Target. High, $ Low, $ Average, $ Current Price, $ VKTX will report FY earnings on 02/05/ Yearly Estimates. Stock Calculator. Investors. Overview · Stock Information · Stock Chart · Historical Price Lookup NASDAQVKTX. Investment Type. Amount invested (in dollars). Analyst Price Targets ; ; Average ; Current ; High. VKTX / Viking Therapeutics, Inc. (NasdaqCM) - Forecast, Price Target, Estimates, Predictions. What is the forecast, or price target, for Viking Therapeutics (VKTX) stock? A. Viking Therapeutics has a consensus price target of $ Q. What is the.
Stock price target for Viking Therapeutics, Inc. VKTX are on downside and on upside. Stock price target for Viking Therapeutics, Inc. VKTX are The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the. VKTX's current price target is $ Learn why top analysts are making this stock forecast for Viking Therapeutics at MarketBeat. Price vs Fair Value VKTX is trading within a range we consider fairly valued. Price. $ Sep 10, The 41 analysts offering price forecasts for Viking Therapeutics have a median target of , with a high estimate of and a low estimate of
The Big 3: TGT, AVGO, CFLT
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Find the latest Viking Therapeutics Inc (VKTX) stock forecast, month price target, predictions and analyst recommendations. Stock Price Forecast. The 9 analysts with month price forecasts for Viking Therapeutics stock have an average target of , with a low estimate of 80 and.
Viking's obesity drug study results are 'almost flawless', says Oppenheimer's Jay Olson